Alosa Health, Inc.
About Alosa Health, Inc.
Alosa Health is a national leader in developing and implementing academic detailing programs to improve prescribing. At our core, we believe that medical decisions should be based on unbiased, evidence-based information. Our mission is to improve patient outcomes by identifying and disseminating the best evidence available, to support health care professionals in providing optimal care to their patients.
Alosa Health’s founder and chief clinical consultant, Dr. Jerry Avorn, pioneered the concept of academic detailing as a way to optimize the prescribing practices of primary care physicians. Over the past decade, we have refined this innovative information delivery method and partnered with state governments, federal agencies, and private organizations to create academic detailing programs and training events. Our programs have expanded beyond prescription drugs to include non-drug therapies and diagnostics as well.
The largest program of Alosa Health is the Independent Drug Information Service (IDIS), the leading state-supported academic detailing program in the country. Our team of medical school physicians has developed a comprehensive portfolio of clinical education materials that provide unbiased information and expert guidance on managing common health problems. The educational module topics are all relevant to primary care, such as type 2 diabetes, chronic pain, and congestive heart failure. Each educational module is written for healthcare professionals and includes a comprehensive literature review, prescriber educational materials, and patient education aids, which are updated regularly. This program is supported by the Pharmaceutical Assistance Contract for the Elderly (PACE) program of the Pennsylvania Department of Aging, the Vermont Health Care Association, and the Vermont Department of Disabilities, Aging, and Independent Living.